A new report from the U.S. Department of Health and Human Services estimates that if the Inflation Reduction Act’s provision capping the cost of insulin at $35 for a month’s supply for Medicare beneficiaries had been in place in 2020, 1.5 million seniors across the country would have saved an average of $500 on insulin for the year.
HHS projects savings on insulin due to Inflation Reduction Act
